{"organizations": [], "uuid": "0a1657cb54f594752ee0ef9e2dd1fcb0701326d3", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180308.html", "section_title": "Archive News &amp; Video for Thursday, 08 Mar 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-turning-point-brands-reports-q4-ad/brief-turning-point-brands-reports-q4-adjusted-earnings-per-share-0-23-idUSASB0C9E6", "country": "US", "domain_rank": 408, "title": "BRIEF-Turning Point Brands Reports Q4 Adjusted Earnings Per Share $0.23", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.003, "site_type": "news", "published": "2018-03-08T19:56:00.000+02:00", "replies_count": 0, "uuid": "0a1657cb54f594752ee0ef9e2dd1fcb0701326d3"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-turning-point-brands-reports-q4-ad/brief-turning-point-brands-reports-q4-adjusted-earnings-per-share-0-23-idUSASB0C9E6", "ord_in_thread": 0, "title": "BRIEF-Turning Point Brands Reports Q4 Adjusted Earnings Per Share $0.23", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "fda", "sentiment": "none"}, {"name": "thomson reuters trust principles", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 8 (Reuters) - Turning Point Brands Inc:\n* TURNING POINT BRANDS, INC. ANNOUNCES FOURTH QUARTER AND FULL YEAR 2017 RESULTS\n* QTRLY EARNINGS PER SHARE $0.18 * ‍CAPITAL EXPENDITURES FOR 2018 ARE EXPECTED TO BE $2 MILLION TO $3 MILLION​\n* TURNING POINT BRANDS - TO CONTINUE SKU RATIONALIZATION EFFORTS WHILE DISCONTINUING PRODUCTS THAT DO NOT WARRANT EXPENSE TO GET FDA COMPLIANCE\n* TURNING POINT - IDENTIFIED PRODUCTS FOR 2018 RATIONALIZATION & ESTIMATE SKU DISCONTINUATIONS WILL UNFAVORABLY IMPACT YOY SALES BY ABOUT $3.5 MILLION Source text for Eikon: Further company coverage:\nOur Standards: The Thomson Reuters Trust Principles.", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-03-08T19:56:00.000+02:00", "crawled": "2018-03-09T14:44:31.000+02:00", "highlightTitle": ""}